Patents Assigned to Johnson & Johnson Vision Care, Inc.
  • Patent number: 10388929
    Abstract: In one example, a battery includes a negative terminal, a positive terminal, an electrolyte contained between the negative terminal and the positive terminal, and a hydrogel layer positioned between and physically separating the negative terminal and the positive terminal.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: August 20, 2019
    Assignees: International Business Machines Corporation, Johnson & Johnson Vision Care, Inc.
    Inventors: Paul S. Andry, Eric Lewandowski, Adam Toner, Daniel Otts, James Daniel Riall, Cornelia T. Yang
  • Patent number: 10381687
    Abstract: Methods and apparatus to form biocompatible energization elements are described. In some embodiments, the methods and apparatus to form the biocompatible energization elements involve forming cavities comprising active cathode chemistry. The active elements of the cathode and anode are sealed with a laminate stack of biocompatible material. In some embodiments, a field of use for the methods and apparatus may include any biocompatible device or product that requires energization elements.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: August 13, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frederick A. Flitsch, Shivkumar Mahadevan, Daniel B. Otts, Randall B. Pugh, James Daniel Riall, Adam Toner
  • Patent number: 10377096
    Abstract: This invention describes methods and apparatus for implementing a Convergence Process to Converge a Lens Design wherein a previous DMD Show may be modified for a subsequent Iteration. In preferred embodiments, an Iterative Loop may be initiated during a Convergence Process wherein one or more of various: techniques, modalities, and thickness correction methods may be implemented.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: August 13, 2019
    Assignee: Johnson & Johnson Vision Care Inc
    Inventors: Christopher Wildsmith, Michael Widman, P. Mark Powell
  • Patent number: 10379380
    Abstract: Translating contact lenses which are truncated for correcting presbyopia and whose design is optimized to maximize translation ability while maintaining comfort when the lens is worn on eye. Truncation of the lenses results in a non-round geometry while still retaining under-lid residency in select portions of the lens itself. Maximum thickness and back surface radius of curvature along with ramp shape can be optimized individually or in combination to maximize translation of the lens relative to the eye, when the lens is positioned on eye.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: August 13, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Pierre-Yves Gerligand, Gregory J. Hofmann, Philippe F. Jubin, Shahrokh Zeinali-Davarani
  • Patent number: 10379381
    Abstract: An optimized contact lens design and method which leverages the strain energy of the system when placed on eye that improves centration, translation, and stabilization characteristics, or any combination thereof, in order to improve both comfort and vision. A contact lens design and methodology wherein the lens-eye resulting strain energy is optimized to achieve the desired function be it centration, translation, or stabilization. Since the lens strain energy is directly driven by the amount of lens deformation, it is possible to control the lens strain energy through the modulus of the material, design of the lens geometry, namely the radii or curvature, peripheral thickness profiles, edge or rim shapes. The surface pressure and/or lens strain energy can be optimized for a given population by averaging the ocular eye shape/surface. Alternatively the lens strain energy can be optimized for a single given eye (i.e., custom design).
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: August 13, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Pierre-Yves Gerligand, Gregory J. Hofmann, Philippe Jubin
  • Patent number: 10371865
    Abstract: Described are silicone hydrogels that are more biocompatible than current ocular materials. The silicone hydrogels are formed from a reactive monomer mixture comprising: a mixture of hydroxyl substituted silicone containing components, at least one polyamide; and at least one hydrophilic monomer. The silicone hydrogels also display a desirable balance of properties, including clarity, oxygen permeability, wettability and desirable protein uptake.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: August 6, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Alexander Guzman
  • Patent number: 10368621
    Abstract: The packages described by this invention all have reduced “head space,” that is, the distance from lid to lens. Packages contain dimples to achieve this reduced head space. Specifically, packages are designed with dimple sag equal to or less than 1.90-mm, or volume displaced equal to or less than 360 ?l. Combined with the existing primary packaging, it has been found that such conditions provide for reduction in folded lens rate during shipping and handling. As well, lenses stored or having an extended time in low head space packages in a “foil down” orientation now have characteristics closer lenses stored in a “foil up orientation.” The packages finally include a foil 3D pattern at a smaller scale than the dimple, by embossing or other methods allowing reduce lens sticking to the foil as well as an added anti-counterfeiting measure.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: August 6, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Vincent Barre, Edward Kernick, Dominic Gourd, Leslie Voss, John McGrath, Sydney Higginbottom
  • Patent number: 10374216
    Abstract: Methods and apparatus to form biocompatible energization elements are described. In some examples, the methods and apparatus to form the biocompatible energization elements involve forming pellets comprising active cathode chemistry. The active elements of the cathode and anode are sealed with a biocompatible material. In some examples, a field of use for the methods and apparatus may include any biocompatible device or product that requires energization elements.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: August 6, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frederick A. Flitsch, Daniel B. Otts, Randall B. Pugh, James Daniel Riall, Adam Toner
  • Patent number: 10370476
    Abstract: Described are silicone hydrogels with high levels of polyamides exhibiting an excellent balance of physical, mechanical, and biological properties. The silicone hydrogels are formed from a reactive monomer mixture comprising: a hydroxylalkyl (meth)acrylate monomer; hydroxyl-containing silicone components; and a polyamide, wherein the polyamide is present in an amount greater than 15 weight percent, based on the total weight of reactive components in the reactive monomer mixture.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: August 6, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Alexander Guzman
  • Patent number: 10367233
    Abstract: Designs, strategies and methods to form energization elements comprising polymer electrolytes are described. In some examples, the biocompatible energization elements may be used in a biomedical device. In some further examples, the biocompatible energization elements may be used in a contact lens.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: July 30, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frederick A. Flitsch, Millburn Ebenezer Jacob Muthu, Daniel B. Otts, Randall B. Pugh, James Daniel Riall, Adam Toner
  • Patent number: 10362934
    Abstract: A computer, a high resolution monitor and a patient interface is utilized to implement a visual contrast sensitivity function measurement test. More specifically, a computerized video system is configured to implement a tilted-grating forced choice contrast sensitivity function test. The invention utilizes known measurement methods for the visual contrast sensitivity function and automates their use by computerizing the system and couples it with a patient-interactive user interface in order to produce an accurate quantitative result.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: July 30, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: John E. Greivenkamp, Jr., Gregory A. Williby
  • Patent number: 10361404
    Abstract: Anode formulations and designs for use in biocompatible energization elements are described. In some examples, a field of use for the apparatus may include any biocompatible device or product that requires energization elements.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: July 23, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frederick A. Flitsch, Daniel B. Otts, Randall B. Pugh, James Daniel Riall, Adam Toner
  • Patent number: 10359646
    Abstract: Contact lenses incorporate high plus or add power profiles that at least one of slow, retard or preventing myopia progression and minimize halo effect. The lens includes a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile that increases from an outer margin of the center zone to a positive power within the at least one treatment zone of greater than +5.00 D.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: July 23, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Noel A. Brennan, Khaled Chehab, Xu Cheng, Michael J. Collins, Manwai Charis Lau, Eric R. Ritchey, Xin Wei
  • Patent number: 10361405
    Abstract: Designs, strategies and methods to form energization elements comprising polymer electrolytes are described. In some examples, the biocompatible energization elements may be used in a biomedical device. In some further examples, the biocompatible energization elements may be used in a contact lens.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: July 23, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Millburn Ebenezer Jacob Muthu, Randall B. Pugh, Adam Toner
  • Patent number: 10359643
    Abstract: A Free-form contact lens and method of making the same. The lens includes a posterior optical quality surface having a concave shape, an opposing anterior surface having a convex shape both of which join at a lens edge that defines an outer periphery of the contact lens, and at least a first lens feature having a predetermined shape and made of a first polymerized Reactive Mixture. The remainder of the lens is made of a second polymerized Reactive Mixture that is different than the first polymerized Reactive Mixture, and that is covalently bonded thereto.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: July 23, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Christopher Wildsmith, Peter W. Sites, Mukul Kanaujia, Joe M. Wood
  • Patent number: 10353115
    Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: July 16, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Azaam Alli, Douglas G. Vanderlaan, James D. Ford, Scott L. Joslin
  • Patent number: 10350793
    Abstract: Disclosed in this specification is a casting cup assembly comprising frontcurve and basecurve molds which of which includes a ring that circumscribes the respective concave and convex mold surface. When the casting cup is assembled, the rings align and minimize de-centering and tilting of the concave and convex mold surfaces which, in turn, reduces edge defects.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: July 16, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Vincent H. Barre, Scott F. Ansell, Gregory L. Berckmiller, Timothy Burkill, Mark McConnell
  • Patent number: 10345619
    Abstract: Thinned, flexible surface regions upon which flexible active components may be utilized to attach flexible active components in space/volume constrained devices, for example, a powered ophthalmic device. Thinned, flexible surface regions foster an avenue for enhanced functionality because various electronic circuits and components can be integrated into polymeric structures.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: July 9, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Adam Toner, James Daniel Riall, Sharika Snook, Dawn Jamisha Owens, Marina Archer
  • Patent number: 10347588
    Abstract: After forming a first electromagnetic radiation blocking layer over a front side of a device wafer, the device wafer is bonded to a handle substrate from the front side. A semiconductor substrate in the device wafer is thinned from its backside. Trenches are formed extending through the device wafer and the first electromagnetic radiation blocking layer such that the device wafer is singulated into semiconductor dies. A second electromagnetic radiation blocking layer portion is formed on a backside surface of and sidewalls surfaces of each of the semiconductor dies such that each of the semiconductor dies are fully encapsulated by the first and second electromagnetic radiation blocking layer portions.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: July 9, 2019
    Assignees: International Business Machines Corporation, JOHNSON & JOHNSON VISION CARE, INC.
    Inventors: Paul S. Andry, Cornelia K. Tsang, Adam Toner
  • Patent number: 10345621
    Abstract: Disclosed are powered or electronic ophthalmic devices or lenses which can have the ability to monitor and sense extreme gaze angle. Also disclosed is the use of extreme gaze angles to control the focal state of the lens as well as for augmenting, control of, or input to, other device parameters of the powered or electronic ophthalmic lens. Applicants have researched and determined what are believed to be acceptable ranges of both upward and downward extreme gaze angles which are not only measurably distinguishable from normally occurring gaze angles associated with everyday activities, but which are still achievable by the wearer if purposeful, as they are still within human eye movement capability.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: July 9, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Ross Franklin, Adam Toner